C14ORF37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.65629979018445E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.85170007000113E-10 |
Normal-vs-Stage2 |
6.31710017628961E-10 |
Normal-vs-Stage3 |
2.46589970664957E-10 |
Normal-vs-Stage4 |
9.37550037605206E-12 |
Stage1-vs-Stage2 |
4.894800E-01 |
Stage1-vs-Stage3 |
9.467400E-01 |
Stage1-vs-Stage4 |
9.69579999999803E-05 |
Stage2-vs-Stage3 |
5.929200E-01 |
Stage2-vs-Stage4 |
4.388200E-04 |
Stage3-vs-Stage4 |
5.921500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.23959978235189E-10 |
Normal-vs-AfricanAmerican |
2.00039984576961E-10 |
Normal-vs-Asian |
9.05789998562057E-09 |
Caucasian-vs-AfricanAmerican |
2.626600E-01 |
Caucasian-vs-Asian |
6.348400E-01 |
AfricanAmerican-vs-Asian |
8.606400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.21569992856041E-10 |
Normal-vs-Female |
1.13300002713146E-09 |
Male-vs-Female |
1.455510E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.0056999677488E-10 |
Normal-vs-Extreme_Weight |
2.72520006561194E-10 |
Normal-vs-Obese |
5.98070037938214E-10 |
Normal-vs-Extreme_Obese |
3.83459997088664E-09 |
Normal_Weight-vs-Extreme_Weight |
3.378800E-01 |
Normal_Weight-vs-Obese |
6.305600E-02 |
Normal_Weight-vs-Extreme_Obese |
4.976000E-01 |
Extreme_Weight-vs-Obese |
3.055400E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.146400E-01 |
Obese-vs-Extreme_Obese |
6.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.68689959170842E-10 |
Normal-vs-Age(41-60Yrs) |
5.80470005395739E-10 |
Normal-vs-Age(61-80Yrs) |
3.08360004197539E-10 |
Normal-vs-Age(81-100Yrs) |
5.27780041892356E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.256200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.287800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.562400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.152200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.171030E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.359800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
7.17069958966476E-10 |
Normal-VS-Type2 PRCC |
9.91789983473268E-11 |
Normal-VS-KIRP CIMP |
5.42260014668727E-10 |
Normal-VS-Unclassified PRCC |
1.06230002572261E-09 |
Type1 PRCC-VS-Type2 PRCC |
7.962200E-04 |
Type1 PRCC-VS-KIRP CIMP |
3.988000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.674400E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.059600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.303930E-02 |
KIRP CIMP-VS-Unclassified PRCC |
2.955800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.60490526318813E-11 |
Normal-vs-N1 |
3.36930483513243E-11 |
Normal-vs-N2 |
5.05310004950132E-09 |
N0-vs-N1 |
9.495200E-01 |
N0-vs-N2 |
4.456800E-01 |
N1-vs-N2 |
5.258800E-01 |
|
|